Researchers have developed a single genome-editing strategy called PERT (Prime-Editing-mediated Readthrough of premature Termination codons) to treat multiple genetic disorders caused by nonsense mutations.
PERT reprograms a cell's gene to override premature stop signals, allowing the cell to produce complete proteins.
The study, published in Nature, involved researchers from the Broad Institute, Harvard University, and the University of Minnesota.
In cultured human cells, PERT achieved 60-80% editing efficiency, significantly higher than the standard method.
In a Hurler syndrome mouse model, PERT restored 1.7-7% of normal enzyme activity in key organs.
Detailed Insights:
Nonsense mutations, which introduce premature stop signals in DNA, account for about a quarter of all disease-causing genetic changes, leading to a wide range of disorders.
PERT leverages the redundancy of tRNA genes by editing a non-essential tRNA gene into a suppressor tRNA, which reads through premature stop signals.
The researchers engineered thousands of variants of four tRNAs (leucine, arginine, tyrosine, and serine) to increase their effectiveness in suppressing premature stop codons.
Prime editing, a precise genome-editing approach, uses a prime-editing guide RNA (pegRNA) to direct the editing machinery to the correct spot on the DNA.
Safety tests indicated that PERT did not alter unrelated parts of the DNA, disturb the cell's overall activity, or disrupt normal protein production.
PERT was tested in cell models of Batten disease, Tay-Sachs disease, and Niemann-Pick C1 disease, all caused by premature stop codons, and showed promising results in restoring enzyme activity.
AAV9, a common gene-therapy vector, was used to deliver the prime-editing components into newborn mice to evaluate PERT in a living organism.
While PERT shows promise, challenges remain in delivery, long-term safety, and performance across different tissues before it can be realistically moved toward patients.
Scientific/Technical Concepts Involved:
Nonsense Mutation: A genetic mutation that introduces a premature stop signal in DNA, halting protein production.
tRNA (transfer RNA): A type of RNA molecule that helps decode mRNA into a protein by transporting specific amino acids.
Prime Editing: A precise genome-editing technique that uses a prime-editing guide RNA (pegRNA) to rewrite DNA sequences.
AAV9 (adeno-associated virus 9): A harmless virus commonly used as a gene-therapy vector to deliver genetic cargo into cells.